CanPath to study the impact and immune response to COVID-19 infection and vaccination
The Canadian Partnership for Tomorrow’s Health (CanPath) COVID-19 Antibody Study is expanding. The Government of Canada is investing $1.9 million through Canada’s COVID-19 Immunity Task […]
New Monthly Access Office Hours
1:00 pm — 2:00 pm
bit.ly
Webinar: The Canadian Network for Advanced Interdisciplinary Methods (CAN-AIM) in Comparative Effectiveness Research
12:00 pm — 1:00 pm
youtu.be
Early results from CanPath’s national study confirm antibody levels are stronger after receiving two doses of COVID-19 vaccine
Initial preliminary results from the Canadian Partnership for Tomorrow’s Health (CanPath) COVID-19 Antibody Study, based on close to 6,000 dried blood spot samples collected between […]
CanPath Whole Genome Sequencing Initiatives
With a biobank containing biospecimens from over 150,000 participants from across Canada, CanPath is a valuable platform for genomics research in Canada and globally. To […]
New Round of Linkage of CANUE Environmental Datasets to CanPath Data
A second round of Canadian Urban Environmental Health Research Consortium (CANUE) environmental exposure datasets have been linked with the national harmonized CanPath datasets and were […]
Webinar: Introducing the CanPath Student Dataset
12:00 pm — 1:00 pm
youtu.be
CanPath Portal Overview
12:00 pm — 1:00 pm
youtube.com
Dr. Robin Urquhart named Scientific Director of Atlantic PATH
CanPath has named Dr. Robin Urquhart have named Dr. Robin Urquhart the new Scientific Director of the Atlantic regional cohort – the Atlantic Partnership for Tomorrow’s Health Study (Atlantic PATH).
National COVID-19 Questionnaire Data Now Available
Over 101,500 CanPath participants from across Canada completed the CanPath COVID-19 Questionnaire in 2020. The first release of this data, including the over 93,000 responses […]